{
    "Trade/Device Name(s)": [
        "AuditTM MicroCVTM Immunoassay Linearity Set"
    ],
    "Submitter Information": "Aalto Scientific, Ltd.",
    "510(k) Number": "K062668",
    "Predicate Device Reference 510(k) Number(s)": [
        "K042318"
    ],
    "Regulatory Class": "Class I",
    "Product Code(s)": [
        "JJY"
    ],
    "Summary Letter Date": "September 8, 2006",
    "Summary Letter Received Date": "September 13, 2006",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 862.1660"
    ],
    "Regulation Name(s)": [
        "Quality control material (assayed and unassayed)"
    ],
    "Analyte Class(es)": [
        "endocrine",
        "chemistry"
    ],
    "Analyte(s)": [
        "Cortisol",
        "Digoxin",
        "Estradiol",
        "Ferritin",
        "Folate",
        "Free T4",
        "FSH",
        "hCG",
        "LH",
        "Progesterone",
        "Prolactin",
        "Testosterone",
        "Total PSA",
        "Total T3",
        "Total T4",
        "TSH",
        "Vitamin B12"
    ],
    "Specimen Type(s)": [
        "Human serum",
        "Bovine serum albumin"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Immunoassay"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Quality control material",
        "Calibration verification material"
    ],
    "Document Summary": "FDA 510(k) summary for AuditTM MicroCVTM Immunoassay Linearity Set, a five-level lyophilized QC material for immunoassay calibration verification and proficiency testing.",
    "Indications for Use Summary": "For proficiency testing and CLIA-directed calibration verification of immunoassay analytes in human/bovine serum albumin matrices using FDA-accepted reagents and appropriate instrumentation.",
    "fda_folder": "Clinical Chemistry"
}